ByTrending Posts
Can Edison Scientific and Population Health Partners’ AI…
Key Highlights The Deal at a Glance Announced on June 29, 2026, the partnership pairs PHP’s proven track…
Can a $2.5 Billion AI Alliance Between Insilico…
Key Highlights The Deal at a Glance Announced at the BIO 2026 International Convention, the collaboration grants Insilico…
Can Sanofi SA’s New AI-Enabled Innovation Hub in…
Key Highlights: AI-Integrated Innovation Hubs Redefine Global R&D ModelsSanofi SA’s launch of its innovation and operations centre in…
Can Sanofi SA’s $1.2 Billion AI-Driven Autoimmune Alliance…
Key Highlights: AI-Powered Biologics Platforms Accelerate Next-Gen Antibody DiscoverySanofi SA’s licensing agreement with Kali Therapeutics Inc highlights the…
Can Eli Lilly and Company’s “Triple-G” AI-Enabled Next-Gen…
Key Highlights: AI-Driven Clinical Design Unlocks Superior Metabolic OutcomesEli Lilly and Company’s late-stage trial results for retatrutide highlight…
Can Novartis AG’s $3 Billion AI-Driven Oncology Bet…
Key Highlights: AI-Led Drug Discovery Accelerates Target Identification and ValidationNovartis AG’s acquisition of SNV4818 from Synnovation Therapeutics, Inc.…
How Will Emerging Drug Pricing Policies Reshape the…
The global biopharmaceutical industry is entering a new policy-driven era as governments intensify efforts to control drug costs,…
Strategic Industry Release: How AI Companies Led Biopharma…
Artificial intelligence companies emerged as critical innovation partners for the global biopharmaceutical industry in 2025, reshaping how drugs…
AI in Life Sciences: A Multi-Billion Dollar Transformation…
Artificial intelligence is rapidly becoming one of the most transformative forces in the life sciences industry. Global investment…
Trending Posts
Latest Stories
Can Edison Scientific and Population Health Partners’ AI Build the Next $10 Billion Biotech?
Key Highlights The Deal at a Glance Announced on June 29, 2026, the partnership pairs…
Can a $2.5 Billion AI Alliance Between Insilico Medicine and SK Biopharmaceuticals Rewrite the Future of Neuroimmune Drug Discovery?
Key Highlights The Deal at a Glance Announced at the BIO 2026 International Convention, the…
Can Sanofi SA’s New AI-Enabled Innovation Hub in China Accelerate Global Drug Development and Reshape Biopharma Operations Across Asia?
Key Highlights: AI-Integrated Innovation Hubs Redefine Global R&D ModelsSanofi SA’s launch of its innovation and…
Can Sanofi SA’s $1.2 Billion AI-Driven Autoimmune Alliance with Kali Therapeutics Inc Unlock Next-Gen Tri-Specific Antibody Therapies and Disrupt Immunology Markets?
Key Highlights: AI-Powered Biologics Platforms Accelerate Next-Gen Antibody DiscoverySanofi SA’s licensing agreement with Kali Therapeutics…
Gallery
